Company Filing History:
Years Active: 2001
Title: Heinrich Rüeger: Innovator in Selective NPY Antagonists
Introduction
Heinrich Rüeger is a notable inventor based in Flüh, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective antagonists for neuropeptide Y (NPY) receptors.
Latest Patents
Rüeger holds a patent for "Selective NPY (Y5) antagonists (tricyclics)." This invention is directed to tricyclic compounds that act as selective antagonists for NPY (Y5) receptors. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of the compound along with a pharmaceutically acceptable carrier. Additionally, the invention describes a process for creating this pharmaceutical composition.
Career Highlights
Heinrich Rüeger is associated with Synaptic Pharmaceutical Corporation, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on innovative solutions that address various medical needs.
Collaborations
Rüeger has collaborated with notable colleagues, including Mohammad R Marzabadi and Peter Bühlmayer, contributing to the advancement of their shared research goals.
Conclusion
Heinrich Rüeger is a distinguished inventor whose work on selective NPY antagonists has the potential to impact the pharmaceutical industry significantly. His contributions reflect a commitment to innovation and the development of effective therapeutic solutions.